In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study

Metal-based drugs represent a rich source of chemical substances of potential interest for the treatment of COVID-19. To this end, we have developed a small but representative panel of nine metal compounds, including both synthesized and commercially available complexes, suitable for medical applica...

Full description

Bibliographic Details
Main Authors: Damiano Cirri, Tiziano Marzo, Iogann Tolbatov, Alessandro Marrone, Francesco Saladini, Ilaria Vicenti, Filippo Dragoni, Adele Boccuto, Luigi Messori
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/12/1858
_version_ 1797506477575897088
author Damiano Cirri
Tiziano Marzo
Iogann Tolbatov
Alessandro Marrone
Francesco Saladini
Ilaria Vicenti
Filippo Dragoni
Adele Boccuto
Luigi Messori
author_facet Damiano Cirri
Tiziano Marzo
Iogann Tolbatov
Alessandro Marrone
Francesco Saladini
Ilaria Vicenti
Filippo Dragoni
Adele Boccuto
Luigi Messori
author_sort Damiano Cirri
collection DOAJ
description Metal-based drugs represent a rich source of chemical substances of potential interest for the treatment of COVID-19. To this end, we have developed a small but representative panel of nine metal compounds, including both synthesized and commercially available complexes, suitable for medical application and tested them in vitro against the SARS-CoV-2 virus. The screening revealed that three compounds from the panel, i.e., the organogold(III) compound Aubipyc, the ruthenium(III) complex KP1019, and antimony trichloride (SbCl<sub>3</sub>), are endowed with notable antiviral properties and an acceptable cytotoxicity profile. These initial findings prompted us to perform a computational study to unveil the likely molecular basis of their antiviral actions. Calculations evidenced that the metalation of nucleophile sites in SARS-CoV-2 proteins or nucleobase strands, induced by Aubipyc, SbCl<sub>3</sub>, and KP1019, is likely to occur. Remarkably, we found that only the deprotonated forms of Cys and Sec residues can react favorably with these metallodrugs. The mechanistic implications of these findings are discussed.
first_indexed 2024-03-10T04:33:12Z
format Article
id doaj.art-d845233acb5041cba0ec503d3f18e86b
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T04:33:12Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-d845233acb5041cba0ec503d3f18e86b2023-11-23T04:00:16ZengMDPI AGBiomolecules2218-273X2021-12-011112185810.3390/biom11121858In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational StudyDamiano Cirri0Tiziano Marzo1Iogann Tolbatov2Alessandro Marrone3Francesco Saladini4Ilaria Vicenti5Filippo Dragoni6Adele Boccuto7Luigi Messori8Laboratory of Metals in Medicine (MetMed), Department of Chemistry “U. Schiff”, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, ItalyDepartment of Pharmacy, University of Pisa, Via Bonanno Pisano 6, 56126 Pisa, ItalyInstitut de Chimie Moleculaire de l’Université de Bourgogne (ICMUB), UMR CNRS 6302, Université de Bourgogne Franche-Comté (UBFC), Avenue Alain Savary 9, 21078 Dijon, FranceDipartimento di Farmacia, Università “G. d’Annunzio” Chieti-Pescara, Via dei Vestini, 66100 Chieti, ItalyDepartment of Medical Biotechnologies, University of Siena, Viale Bracci 16, 53100 Siena, ItalyDepartment of Medical Biotechnologies, University of Siena, Viale Bracci 16, 53100 Siena, ItalyDepartment of Medical Biotechnologies, University of Siena, Viale Bracci 16, 53100 Siena, ItalyDepartment of Medical Biotechnologies, University of Siena, Viale Bracci 16, 53100 Siena, ItalyDepartment of Chemistry and Industrial Chemistry (DCCI), University of Pisa, Via G. Moruzzi 13, 56124 Pisa, ItalyMetal-based drugs represent a rich source of chemical substances of potential interest for the treatment of COVID-19. To this end, we have developed a small but representative panel of nine metal compounds, including both synthesized and commercially available complexes, suitable for medical application and tested them in vitro against the SARS-CoV-2 virus. The screening revealed that three compounds from the panel, i.e., the organogold(III) compound Aubipyc, the ruthenium(III) complex KP1019, and antimony trichloride (SbCl<sub>3</sub>), are endowed with notable antiviral properties and an acceptable cytotoxicity profile. These initial findings prompted us to perform a computational study to unveil the likely molecular basis of their antiviral actions. Calculations evidenced that the metalation of nucleophile sites in SARS-CoV-2 proteins or nucleobase strands, induced by Aubipyc, SbCl<sub>3</sub>, and KP1019, is likely to occur. Remarkably, we found that only the deprotonated forms of Cys and Sec residues can react favorably with these metallodrugs. The mechanistic implications of these findings are discussed.https://www.mdpi.com/2218-273X/11/12/1858SARS-CoV-2COVID-19antiviral drugsmetallodrugsgoldruthenium
spellingShingle Damiano Cirri
Tiziano Marzo
Iogann Tolbatov
Alessandro Marrone
Francesco Saladini
Ilaria Vicenti
Filippo Dragoni
Adele Boccuto
Luigi Messori
In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
Biomolecules
SARS-CoV-2
COVID-19
antiviral drugs
metallodrugs
gold
ruthenium
title In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
title_full In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
title_fullStr In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
title_full_unstemmed In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
title_short In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
title_sort in vitro anti sars cov 2 activity of selected metal compounds and potential molecular basis for their actions based on computational study
topic SARS-CoV-2
COVID-19
antiviral drugs
metallodrugs
gold
ruthenium
url https://www.mdpi.com/2218-273X/11/12/1858
work_keys_str_mv AT damianocirri invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy
AT tizianomarzo invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy
AT ioganntolbatov invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy
AT alessandromarrone invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy
AT francescosaladini invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy
AT ilariavicenti invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy
AT filippodragoni invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy
AT adeleboccuto invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy
AT luigimessori invitroantisarscov2activityofselectedmetalcompoundsandpotentialmolecularbasisfortheiractionsbasedoncomputationalstudy